These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24720)

  • 41. Behavioral study after local injection of 6-hydroxydopamine into the nucleus accumbens in the rat.
    Taghzouti K; Simon H; Louilot A; Herman JP; Le Moal M
    Brain Res; 1985 Sep; 344(1):9-20. PubMed ID: 3930001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of neurotensin with brain dopamine systems.
    Nemeroff CB; Hernandez DE; Luttinger D; Kalivas PW; Prange AJ
    Ann N Y Acad Sci; 1982; 400():330-44. PubMed ID: 6132577
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):121P-122P. PubMed ID: 454917
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinction between dopaminergic and serotonergic components of neuroleptic binding sites in limbic brain areas.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1979; 28(3):447-8. PubMed ID: 34403
    [No Abstract]   [Full Text] [Related]  

  • 47. Uniquely, gamma-endorphin induces an effect that is both opiate- and neuroleptic-like.
    van Ree JM; Gaffori O
    Life Sci; 1983; 33 Suppl 1():619-22. PubMed ID: 6198576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antagonism by haloperidol of the suppression of exploratory locomotor activity induced by the local application of (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine into the nucleus accumbens of the rat.
    Ahlenius S; Svensson L; Hillegaart V; Thorberg O
    Experientia; 1984 Aug; 40(8):858-9. PubMed ID: 6468602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.
    Carr GD; White NM
    Life Sci; 1983 Dec; 33(25):2551-7. PubMed ID: 6645814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats.
    Fulford AJ; Marsden CA
    Neuroscience; 2007 Oct; 149(2):392-400. PubMed ID: 17869434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine microinjection into the nucleus accumbens: correlation between metabolism and behavior.
    Kalivas PW; Miller JS
    Biochem Pharmacol; 1985 Jan; 34(2):284-6. PubMed ID: 3966931
    [No Abstract]   [Full Text] [Related]  

  • 52. 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.
    Beart PM; Gundlach AL
    Br J Pharmacol; 1980 Jun; 69(2):241-7. PubMed ID: 6108139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The manifold actions of neurotensin: a first synthesis.
    Prange AJ; Nemeroff CB
    Ann N Y Acad Sci; 1982; 400():368-75. PubMed ID: 6132578
    [No Abstract]   [Full Text] [Related]  

  • 54. Neurochemical aspects of morphine tolerance in the freely moving and behaving animal: voltammetric studies.
    Broderick PA; Phelan FT
    Prog Clin Biol Res; 1990; 328():501-6. PubMed ID: 2304965
    [No Abstract]   [Full Text] [Related]  

  • 55. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives.
    Gundlach AL; Christie MJ; Beart PM
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interaction of chlordiazepoxide and sodium valproate in the nucleus accumbens of the rat.
    Kuruvilla A; Uretsky N
    Life Sci; 1981 Jan; 28(4):393-9. PubMed ID: 6783802
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscimol a GABA-agonist injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility.
    Scheel-Krũger J; Cools AR; van Wel PM
    Life Sci; 1977 Dec; 21(11):1697-702. PubMed ID: 563960
    [No Abstract]   [Full Text] [Related]  

  • 60. Differential actions of substituted benzamides on pre- and postsynaptic dopamine receptor mechanisms in the nucleus accumbens.
    Costall B; Hui SC; Naylor RJ
    J Pharm Pharmacol; 1980 Aug; 32(8):594-6. PubMed ID: 6106706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.